Constellation Brands (STZ) Stock Forecast & Price Target

Constellation Brands is viewed favorably because its core beer franchise remains a high-quality earnings engine, with more than 90% of revenue tied to Mexican imports led by Modelo Especial and Corona, and management’s FY'27 framework still calls for consolidated net sales of -1% to +1% with Beer operating margins of 37% to 38% and EPS of $11.20-$11.90. The bullish case is further supported by recent evidence of share gains, broadly healthy depletions, a June volume recovery helped by easing gas prices and event-driven consumption, and a disciplined portfolio that has been pruned of weaker mainstream wine assets, which should improve consistency and profitability. Although Q2 and Q3 will face margin pressure from marketing spending above 10% of sales and Veracruz-related SG&A, the company’s strong water stewardship, ongoing distribution and innovation gains, and management’s willingness to reset expectations conservatively make the outlook for beating guidance credible.

Constellation Brands is facing a fundamentally constrained outlook because more than 90% of revenue comes from Mexican beer imports under Modelo and Corona, leaving the company highly exposed to U.S. beer-category softness, Hispanic-consumer weakness, and any disruption from Mexico production issues or tariffs while having limited international diversification. Management’s reiterated FY'27 guidance also implies margin pressure, since Beer marketing is expected to exceed 10% of sales in Q2 and Q3, creating a sequential headwind on Beer operating margins even though F1Q27 organic revenue still grew 2.0% and EPS came in at $3.43. Beyond beer, the remaining wine and spirits business is still challenged by share loss and price competition, and the 10% Canopy Growth stake plus the 50/50 Owens-Illinois Mexico JV add complexity without offsetting the core business’s reliance on a category where long-term assumptions still point to roughly -1% topline growth, ~32% peak margins, and only ~1.2% terminal growth.